NCT05445778 2026-02-23
GLORIOSA
AbbVie
Phase 3 Recruiting
Clinical Trials
4 trialsNCT05041257 2026-01-09
PICCOLO
AbbVie
Phase 2 Completed
NCT05456685 2025-10-28
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
AbbVie
Phase 2 Active not recruiting
NCT01609556 2021-02-17
IMGN853-0401
ImmunoGen, Inc.
Phase 1 Completed